Relationship between PTEN and Livin expression and malignancy of renal cell carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2681-2685

  Cheng, Tao ^a   Zhang, Jian Guo ^a   Cheng, Yuan He ^a   Gao, Zhong Wei ^a   Ren, Xiao Qiang ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Immunohistochemistry; Livin; PTEN; Renal clear cell carcinoma (RCCC)

Indexed keywords

EID: 84874049240     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2681     Document Type: Article

References (21)

1. Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D. (2001). Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett, 495, 56-60.
2. Brenner W, Färber G, Herget T, et al. (2002). Loss of tumor suppressor protein PTEN during renal carcinogenesis. Int J Canaer, 99, 53-7.
3. Feng Y, Tian ZM, Wan MX, Zheng ZB. (2008). Low intensity ultrasound-induced apoptosis in human gastric carcinoma cells. World J Gastroenterol, 14, 4873-9.
4. Gangar SC, Koul A (2008). Histochemical, ultrastructural, and biochemical evidences for Azadirachta indica-induced apoptosis in benzo(a)pyrene-induced murine forestomach tumors. J Environ Pathof Toxicol Oncol, 27, 219-32.
5. Hager M (2007). PTEN expression in renal cell carcinoma and progonosis. Pathology, 39, 482-5.
6. Huang J, Kontos CD (2002). Moddulates vaseular endotheliad growth factor-mediated signaling and angiogenic effects. J Biol Chem, 277, 10760-6.
7. Ka H, Hunt JS (2003). Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol, 163, 413-22.
8. Kasof GM, Gomes BC (2001). Livin, a novel inhibitor of apoptosis protein Family member. J Biol Chem, 276, 3238-46.
9. Li DM, Sun H (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosin ephosphates regulated by transforming growth factor β. Cancer Res, 57, 2124-9.
10. Li RH (2009). Livin and PTEN in colorectal cancer tissues and its significance. Chin J integrated traditional and Western Med, 16, 247-8.
11. Nachmias B, Mizrahi S, Elmalech M, et al. (2007). Manipulation of NK cytotoxicitv by the IAP family member Livin. Eur J Immunol, 37, 3467-6.
12. Ni JH, Xin J, Wu BC, Xin MH, Wu WF (2011). Livin and PTEN in renal cell carcinoma and its clinical significance. Practical J Cancer, 26, 42-4.
13. Rasheed BK, Stenzel TT, Melendon RE, et al. (1997). PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res, 57, 4187-90.
14. Sui CD, Miao B (2009). PTEN and Livin in tongue squamous cell carcinoma and its clinical significance. Heilongjiang Pharmaceutical Science, 32, 26-7.
15. Sun CH, Chang YH, Pan CC (2011). Activation of the p13k/ Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder. Hisopathologh, 58, 1054-63.
16. Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N (2004). Expression of survivin mRNA and Livin mRNA in non-small-cell lung cancer. Lung Cancer, 46, 299-304.
17. Trotman LC, Wang X, A1imonti A, et al. (2007). Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell, 128, 141-56.
18. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM (2000). LIVIN, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol, 10, 1359-66.
19. Xu ST, Yan CY, Huang YH, Ding X (2010). Research on expression of livin in human renal cell carcinoma. Med J West China, 22, 217-9.
20. Zhang Q, Gao Y, Wang XL, et al. (2010). In esophageal squamous cell carcinoma tissue PTEN, Livin changes in protein expression and significance. Shandong Med J, 50, 52-3.
21. Zhao Y, Deng X, Wang Q (2009). Livin, Smac/DIABLO in stomach tissue PTEN and expression and the correlation and gastric cancer. World Chinese J Digestol, 17, 1303-11.